Fighting to end tuberculosis

Dr Helen McShane at the University of Oxford and the Oxford-Emergent Tuberculosis Consortium Ltd have received a Strategic Award to part-fund the first trial to test efficacy of the new TB vaccine candidate, MVA85A, for potential efficacy in South African infants.

In the video below, Dr McShane discusses the new vaccine candidate and these trials (running time: 4 min 53 s).

Sorry, but you need Flash Player 8 or higher to view the media player Download Flash

Read the transcript [PDF 148KB]